DBNPA Approved for PT11 Under BPR
On March 18, the European Commission officially published the approval date for 2,2-dibromo-2-cyanoacetamide (DBNPA) for PT11. Following a comprehensive technical evaluation, DBNPA approved for PT11 has finally become a reality under the Biocidal Products Regulation (BPR). This decision, recorded in the Official Journal of the European Union, establishes the definitive conditions for companies within the sector to market and utilize this substance for specific preservation applications.
The approval date for DBNPA (PT11) is July 1st, 2027.
Strategic Applications and Uses
DBNPA is a fast-acting, broad-spectrum substance essential in industrial environments. Its approval focuses on Product Type 11 (PT11), specifically intended for the preservation of cooling systems and industrial liquid processes. It serves as a vital tool for controlling microbiological proliferation in cooling towers, evaporative condensers, and industrial water systems. Its use is widespread across the industry, as few alternatives can match its ability to guarantee both operational efficiency and the sanitary safety of facilities.
Risks and Substitution Criteria
Despite its effectiveness, the approval comes with strict limitations. Due to its intrinsic properties, the substance meets certain exclusion criteria, which automatically classifies it as a candidate for substitution. For this reason, the European Commission has restricted the duration of its authorization to only 5 years, rather than the standard 10-year period.
The risks associated with the product primarily focus on its toxicity to the aquatic environment and the necessity for robust risk mitigation measures for operators. Compliance with exposure limits and proper discharge management will be indispensable requirements for all future product authorizations.
Ensure Product Compliance with Nordiik
The publication of the approval date triggers the final countdown for submitting product authorization dossiers under the BPR. Contact Nordiik today to prepare your BPR authorization aaplication for authorisation and ensure the continued marketing of your products without interruption.
You can find the official document regarding the approval date publication here: OJ_L_202600577_EN_TXT
Source: EC
